James Levin

James Levin is a highly experienced professional in the field of microbiology and pharmacology, currently serving as the Director of Anti-infective Pharmacology at Qpex Biopharma since November 2024. Prior to this role, James held significant positions at Cidara Therapeutics, including Senior Director of Preclinical Development, where responsibilities encompassed the development of anti-virals and immuno-oncology therapeutics, as well as leading the development of anti-infectives. Additional experience includes serving as Principal Consultant at MolSci-SD, and holding various leadership roles in therapeutic development and microbiology at Kent BioSciences, Gemini Science, and Quorex Pharmaceuticals. James's academic background includes a Ph.D. in Microbiology from the University of Maryland and a Bachelor's degree in Medical Microbiology from California State University at Chico.